ChromaCode has filed a notice of an exempt offering of securities to raise $38,000,000.00 in Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, ChromaCode is raising $38,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Mark Mcdonough played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About ChromaCode
ChromaCode is a molecular diagnostics company with a bioinformatics focus and pedigree from Illumina, Google[x], Luminex, and Caltech. We leverage patented mathematical methods and algorithmic enhancements to enrich signal processing from the most popular life science instrumentation. We are using this to extract new information on biochemistry reactions and substantially increase the performance capabilities of todays gold-standard biochemical assays at a very low cost.
To learn more about ChromaCode, visit http://chromacode.com/
Contact:
Mark Mcdonough, Chief Executive Officer
442-244-4370
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.